CEO Cristiana Pires receives 2022 RFS Award for publication in Cellular Reprogramming journal

Posted 7 August, 2023

Asgard’s Therapeutics CEO Cristiana Pires has been honored with the prestigious 2022 annual¬†Rosalind Franklin Society¬†(RFS), in partnership with Mary Ann Libert, Inc., publishers, Award in Science for her publication in Cellular Reprogramming journal, co-authored with Filipe Pereira, recognizing exceptional contributions of women and underrepresented minority scientists, physicians, and engineers.